- Endotracheal intubation:
- Adult:
- Induction: IV 0.6mg/kg/dose *1
- Maintenance: IV 0.1-0.2 mg/kg repeat PRN OR continuous infusion 0.01-0.012 mg/kg/min
- Adult:
-
- 3 months-14 years:
- Induction: Initially 0.6mg/kg IV
- Maintenance: IV 0.075-0.125mg/kg IV OR continuous IV infusion 0.012mcg/kg/min
- 3 months-14 years:
-
- >14 years:
- Induction: IV 0.45-0.6 mg/kg IV
- Maintenance: IV 0.1-0.2mg/kg repeat PRN OR continuous IV infusion 0.01-0.012mg/kg/min IV
- >14 years:
- Rapid sequence intubation:
- IV 0.6-1.2 mg/kg/dose *1
- IV 0.6-1.2 mg/kg/dose *1
- Neuromuscular blockade:
- Induction:
- Adults: IV 0.45-1.2mg/kg/dose *1
- <17 years: IV 0.6mg/kg/dose *1
- Induction:
-
- Maintenance:
- Adults: IV 0.1-0.2mg/kg/dose PRN OR 10-12mcg/kg/min, then 4-16mcg/kg/min
- <17 years, isoflurane/nitrous oxide anesthesia: IV 0.15mg/kg/dose PRN OR IV 7-10mcg/kg/min
- 3 months-14 years, halothane anesthesia: IV 0.075-0.125mg/kg/dose PRN OR 12mcg/kg/min
- Maintenance:
Injection: 10mg/mL
- Administer IV only
- To be refrigerated
Neuromuscular blocker
It antagonizes motor endplate acetylcholine receptors inhibiting depolarization
- Transient hypotension
- Hypertension
- Tachycardia
- Hypersensitivity
- Lack of ventilatory support, neuromuscular disease
- Other neuromuscular blocking agents
None remarkable
Drug Status
Availability | Prescription only |
Pregnancy | Category B |
Breastfeeding | Weigh risk vs benefit |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Esmeron | 50mg/5mL | Injection | 10’s | MSD Ltd | Imperial Managed |
Rocuronium | 50mg/5mL | Injection | 10’s | Hameln Pharma | Hameln Pharma |